Alzheimer’s disease affects millions of people around the world and is one of the leading causes of memory loss and cognitive decline in older adults. One of the biggest challenges with this condition is that it is often diagnosed too late.
By the time clear symptoms appear, such as memory problems and confusion, significant damage has already occurred in the brain. This makes early detection extremely important, especially as new treatments are being developed that may work best in the early stages of the disease.
A new study from researchers at Duke Health offers a promising new way to detect Alzheimer’s earlier than ever before. The study, published in Nature Communications, shows that a simple nasal swab may be able to identify early biological changes linked to Alzheimer’s, even before a person shows any symptoms.
The idea behind this research is based on the connection between the nose and the brain. Deep inside the upper part of the nose are special nerve cells that are directly linked to the brain.
These cells are involved in the sense of smell and are part of the same system that can be affected early in Alzheimer’s disease. Because of this close connection, scientists believe that studying these cells may provide important clues about what is happening in the brain.
In the study, researchers used a gentle and quick procedure to collect cells from this area. After applying a numbing spray, a clinician carefully inserted a small brush into the upper part of the nose. The process only took a few minutes and was done in an outpatient setting, meaning patients did not need to stay in a hospital.
Once the cells were collected, the researchers analyzed them in detail. They looked at which genes were active inside the cells.
Gene activity can show how cells are functioning and whether they are under stress or affected by disease. By studying these patterns, the researchers were able to identify clear differences between people with Alzheimer’s and those without it.
The study included 22 participants. Although this is a relatively small number, the analysis was very detailed. The team examined thousands of genes across hundreds of thousands of cells, resulting in millions of data points. Despite the small sample size, the results were strong.
The researchers found that the nasal swab could detect early changes in both nerve cells and immune cells. These changes were present not only in people who had already been diagnosed with Alzheimer’s, but also in those who showed early biological signs of the disease without any noticeable symptoms.
Using a combined gene score based on the nasal cells, the test was able to correctly distinguish between people with early or diagnosed Alzheimer’s and healthy individuals about 81 percent of the time. This level of accuracy is promising, especially for a simple and non-invasive test.
One important advantage of this method is that it studies living cells. Much of what scientists know about Alzheimer’s comes from studying brain tissue after death. This new approach allows researchers to observe active biological processes in living patients, which could lead to better understanding and earlier intervention.
Current blood tests for Alzheimer’s can detect certain markers of the disease, but these markers often appear later in the disease process. In contrast, the nasal swab may capture earlier changes, providing a more direct and timely signal of disease risk.
The study also highlights the human side of research. One participant joined the study in memory of her sister, who had young-onset Alzheimer’s. Her experience reflects the emotional impact of the disease and the importance of finding better ways to detect and treat it earlier.
While the results are encouraging, there are still limitations. The study involved a small group of participants, so larger studies are needed to confirm the findings. In addition, the test is not yet ready for routine use in clinics. More research is needed to refine the method and ensure its reliability.
Researchers are now working to expand the study to larger populations and to explore whether this nasal swab can also be used to monitor how patients respond to treatment over time.
Overall, this study offers a new and hopeful direction in Alzheimer’s research. A quick and simple nasal swab could one day help doctors detect the disease much earlier, giving patients a better chance to receive treatment before serious damage occurs. Early diagnosis could make a meaningful difference in the lives of patients and their families.
If you care about Alzheimer’s, please read studies about the likely cause of Alzheimer’s disease, and new non-drug treatment that could help prevent Alzheimer’s.
For more health information, please see recent studies about diet that may help prevent Alzheimer’s, and results showing some dementia cases could be prevented by changing these 12 things.
Copyright © 2026 Knowridge Science Report. All rights reserved.
